Simply Put: AstraZeneca COVID-19 vaccine

Protection against COVID-19 infection, severe disease falls quickly after AstraZeneca 2nd dose: Lancet

Begins to wane after 18-19 weeks; study stresses on need for booster dose 

Pfizer withdraws application for Emergency Use Authorisation in India

The company will resubmit application after getting more data

COVID-19 vaccine update: People above 45 eligible for jabs from April 1

Ministry of Home Affairs releases updated guidelines for COVID-19 control

Govt neither denies nor accepts adverse event in Serum Institute COVID-19 vaccine trial

Health secretary claims all procedures followed but refuses to divulge details

COVID-19: Next virus could be worse, AstraZeneca vaccine creator Sarah Gilbert says

Research that has not been peer reviewed says that Omicron may be more infectious, but not severe  

COVID-19 vaccines: Did a delayed second dose give the delta variant an evolutionary helping hand?

Those with a single dose of the Pfizer or AstraZeneca vaccine less-protected than those with 2 doses: Public Health England

India readies for COVID-19 vaccination but vexed questions on the solution remain

The risks the country needs to prepare for, precautions it needs to take, the logistics required and, above all, the implications of it all for …

COVID-19: First few peer reviewed studies suggest vaccine induced antibodies fail to protect from Omicron

The studies, published in Nature, covered Oxford-AstraZeneca vaccine, but not India’s indigenous Covaxin

Oxford-AstraZeneca COVID-19 vaccine: What do WHO recommendations say

Health workers at high risk of exposure and older people — including those aged 65 or older — should be given priority for Oxford / …

COVID-19 vaccine update: South Africa may return Serum Institute of India doses

The WHO has approved the Oxford-AstraZeneca coronavirus jab for emergency use. This means the vaccine can be rolled out globally 

COVID-19 vaccine update: AstraZeneca vaccinations should continue, benefits outweigh risks, says WHO

Strategic advisory group of experts on immunization called the one-dose Janssen shot as a safe and lifesaving addition to Pfizer, Moderna and …

COVID-19 vaccines for all: Decoding global tenders by states

At least a dozen Indian states have floated or will float tenders for procuring vaccines and will also bear the cost

Gujarat recipients gung-ho on COVID-19 vaccine

The state will vaccinate about 440,000 healthcare workers and 355,000 frontline workers in the first round

COVID-19 vaccine: Oxford-AstraZeneca up to 90% effective in late stage trial

Adenovirus vaccine can be stored at 2-8°C; company to apply for emergency authorisation

COVID-19 Challenge 2021: How does the world overcome vaccine shortage

The pharmaceuticals industry must come together to ensure all adults are vaccinated against the novel coronavirus; …

UK, South African, Brazilian: A virologist explains each COVID-19 variant, what they mean for the pandemic

The take-home message is that variants will emerge, and we need to closely monitor their spread

What COVID-19 vaccine side effects might I expect?

In the vast majority of cases, any side effect you feel will be over within a few days, and there is no reason for concern

DCGI clears Bharat Biotech, SII COVID-19 vaccines but efficacy question unanswered

CDSCO official says BB vaccine to be used in public but to exclude people with COVID-19, other infections

Decision on emergency authorisation for SII, Bharat Biotech’s COVID-19 vaccines deferred

Both manufacturers have been asked for more data before a final decision can be reached  

Coronavirus update: AstraZeneca halts global vaccine trials

COVID-19 has affected 19 sectors in India that were not under stress earlier, with a total Rs 15.5 lakh crore outstanding debt; retail and …